Michael Gibbs

Michael Gibbs has work experience in various roles and industries. In 2015, they worked as a Validation Technologist at Sanofi Pasteur until February 2017. From February to June 2017, they served as a Commissioning and Qualification Specialist at Therapure Biopharma Inc. In 2017, they joined Brevitas Consulting Inc. as a Consultant, where they worked until July 2018. Michael then worked as a Consultant at First Derivatives from October 2019 to July 2021. From July 2021 to January 2022, they worked as a Consultant at CONTAX Inc. Currently, they are working as a Business Analyst at d1g1t Inc. since January 2022.

Michael Gibbs completed their Bachelor's of Engineering Science (BESc) in Chemical Engineering from Western University between 2008 and 2013. Michael then pursued a Master's of Engineering (MEng) in Industrial Engineering - Financial Engineering from the University of Toronto between 2018 and 2019. In addition to their formal education, Michael also obtained certifications including Bloomberg Market Concepts (BMC) from Bloomberg LP and Canadian Securities Course (CSC) from the Canadian Securities Institute. Furthermore, they obtained a Google Data Analytics Professional Certificate from Google, although the specific dates for this certification are not provided.